Ensem Therapeutics, Inc. (ENSEM), a pioneering drug discovery and development company that leverages its unique Kinetic ...

Preclinical and clinical data demonstrate that neutralizing GDF-15 with visugromab effectively alleviates cancer-induced cachexia, characterized by severe weight and muscle mass loss Patients ...

Preclinical Data with OPN-6602 in Multiple Myeloma Show 100% Tumor Regression in Combination Treatment Studies Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and develop ...

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...

Molecular Cellular Pharmacology Graduate Program, University of Wisconsin-Madison, Madison, USA Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan ...

The collaboration aligns with a broader trend, as seen with ChatGPT’s Advanced Voice Mode and Microsoft’s Copilot Voice. Image Credit: Anthropic The future of computer interaction might not involve a ...

Open Source Generative Process Automation (i.e. Generative RPA). AI-First Process Automation with Large ([Language (LLMs) / Action (LAMs) / Multimodal (LMMs)] / Visual Language (VLMs)) Models ...

in a non-xenograft cell line, will give rise to new insights that are difficult to obtain using mouse tumours only. Wu and colleagues 32 have demonstrated that using the breast HIM model ...

The NHS’s top A&E doctor is urging the public to use 111 services this winter, as the health service launches its annual campaign with adverts across online video, radio, podcasts and social media.

We aimed to develop a machine learning (ML) model to predict overt DIC in critically ill colorectal cancer (CRC) patients using clinical features and laboratory indicators. Methods: This retrospective ...